Last quarter (Q4 2023), Molecular Partners's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Molecular Partners's net income was $―. See Molecular Partners’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 14.09M	$ 7.04M	$ 189.60M	$ 9.75M	$ 9.34M	$ 20.38M
Cost of Revenue	$ ―	$ ―	$ -72.99M	$ -73.17M	$ ―	$ ―
Gross Profit	$ ―	$ 7.04M	$ 189.54M	$ 9.33M	$ ―	$ ―
Operating Expense	$ 35.07M	$ 67.29M	$ 73.61M	$ 73.17M	$ 67.67M	$ 57.04M
Operating Income	$ -20.99M	$ -60.26M	$ 115.93M	$ -63.84M	$ -58.33M	$ -36.66M
Net Non Operating Interest Income Expense	$ 53.00K	$ 4.23M	$ 1.86M	$ 191.00K	$ 63.00K	$ 1.50M
Other Income Expense	$ 3.09M	$ 853.00K	$ -5.38M	$ -424.00K	$ -4.51M	$ -1.11M
Pretax Income	$ -17.84M	$ -61.98M	$ 117.85M	$ -63.78M	$ -62.77M	$ -36.27M
Tax Provision	-	$ ―	$ ―	$ 2.00K	$ -11.00K	$ 17.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -17.84M	$ -61.98M	$ 123.17M	$ -55.78M	$ -62.76M	$ -36.29M
Basic EPS	$ ―	$ -1.89	$ 3.63	$ -2.06	$ ―	$ ―
Diluted EPS	$ ―	$ -1.89	$ 3.54	$ -2.06	$ ―	$ ―
Basic Average Shares	$ ―	$ 32.77M	$ 32.47M	$ 31.01M	$ ―	$ ―
Diluted Average Shares	$ ―	$ 32.77M	$ 34.79M	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 35.07M	$ 67.29M	$ 619.00K	$ ―	$ 67.67M	$ 57.04M
Net Income From Continuing And Discontinued Operation	$ -17.84M	$ -61.98M	$ 123.17M	$ -55.78M	$ -62.76M	$ -36.29M
Normalized Income	$ -20.93M	$ ―	$ ―	$ ―	$ -58.25M	$ -35.38M
Interest Expense	$ 350.00K	$ ―	$ ―	$ ―	$ 295.00K	$ 64.00K
EBIT	$ -17.49M	$ ―	$ 117.85M	$ -63.78M	$ -62.48M	$ -36.21M
EBITDA	$ -16.33M	$ ―	$ 120.24M	$ -61.22M	$ -59.59M	$ -33.74M

Currency in USD

Molecular Partners Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing